MLSS

Milestone Scientific, Inc. Common Stock

MLSS
Closed
$0.35
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 15 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
Country

US

CEO

Mr. Eric Hines

IPO date

1995

Employees

15

ISIN

US59935P2092

Key stats

Open

$0.41

Volume

66.53K

Market cap

$31.75M

Prev. close

$0.35

Impl / hst vl

-

Open interest

$0.00

$0.35

Day’s Range

$0.41

$0.22

52W Range

$0.48

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
2.60
P/B
10.14
Current ratio
1.51
Debt / Equity
-0.15
ROE
-166.28%
Gross margin
72.34%
Income growth
-22.99%
FCF growth
-137.17

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$1.02
The top 4 analysts forecasts that 12-month price may increase by 191.43%, with a low of $1.01 and a high of $1.05
$1.01
Low
$1.02
Avg
$1.05
High
Current price

Earnings

Q1 ‘26 revenue
$2.16M
Q1 ‘26 net income
-$839.90K
Revenue
Net income
Previous EPS
-$0.01
Estimate EPS
-$0.02
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply